Cholesterol emboli syndrome history and symptoms: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cholesterol emboli syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Reference...")
 
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cholesterol emboli syndrome}}
{{Cholesterol emboli syndrome}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}} {{AE}}{{NN}}
==Overview==
Clinical presentation is variable and depends on the organ involved by cholesterol crystals. Due to cholesterol embolization, many organs such as skin, kidneys, heart, gastrointestinal tract, nervous system, eyes, and skeletal muscles can be involved.
==History==
*Obtaining the history is the essential for making a diagnosis of [[cholesterol emboli syndrome]]. <ref name="Ozkok2019">{{cite journal|last1=Ozkok|first1=Abdullah|title=<p>Cholesterol-embolization syndrome: current perspectives</p>|journal=Vascular Health and Risk Management|volume=Volume 15|year=2019|pages=209–220|issn=1178-2048|doi=10.2147/VHRM.S175150}}</ref>
*A positive history of [[atherosclerosis]] and [[cardiovascular]] interventions such as [[angiography]] is suggestive of [[cholesterol emboli syndrome]]. <ref name="Ozkok2019">{{cite journal|last1=Ozkok|first1=Abdullah|title=<p>Cholesterol-embolization syndrome: current perspectives</p>|journal=Vascular Health and Risk Management|volume=Volume 15|year=2019|pages=209–220|issn=1178-2048|doi=10.2147/VHRM.S175150}}</ref>
*Clinical presentation is variable and depends on the organ involved by cholesterol crystals.
==Symptoms==
*The most common symptoms of [[cholesterol emboli syndrome]] include<ref name="Ozkok2019">{{cite journal|last1=Ozkok|first1=Abdullah|title=<p>Cholesterol-embolization syndrome: current perspectives</p>|journal=Vascular Health and Risk Management|volume=Volume 15|year=2019|pages=209–220|issn=1178-2048|doi=10.2147/VHRM.S175150}}</ref><ref name="Falanga1986">{{cite journal|last1=Falanga|first1=Vincent|title=The Cutaneous Manifestations of Cholesterol Crystal Embolization|journal=Archives of Dermatology|volume=122|issue=10|year=1986|pages=1194|issn=0003-987X|doi=10.1001/archderm.1986.01660220112024}}</ref><ref name="QuinonesSaric2013">{{cite journal|last1=Quinones|first1=Adriana|last2=Saric|first2=Muhamed|title=The Cholesterol Emboli Syndrome in Atherosclerosis|journal=Current Atherosclerosis Reports|volume=15|issue=4|year=2013|issn=1523-3804|doi=10.1007/s11883-013-0315-y}}</ref><ref name="SaricKronzon2011">{{cite journal|last1=Saric|first1=Muhamed|last2=Kronzon|first2=Itzhak|title=Cholesterol embolization syndrome|journal=Current Opinion in Cardiology|volume=26|issue=6|year=2011|pages=472–479|issn=0268-4705|doi=10.1097/HCO.0b013e32834b7fdd}}</ref>
**Non-specific symptoms
***[[Fever]]
***[[loss of appetite]]
***[[Fatigue]]
***[[weight loss]]
***[[muscle ache]]
**Cutaneous
***[[livedo reticularis]]
***[[Blue toe syndrome]]
***[[petechiae]] and [[purpura]]
***[[cyanosis]]
***[[Gangrene]]
**Heart
***[[myocardial infarction]]
**Kidney
***[[acute kidney injury]]
****[[nausea]], [[vomiting]], [[electrolyte]] disturbances
***[[chronic kidney failure]]
***[[end stage renal disease]]
***[[focal segmental glomerulonephritis]]
**Gastrointestinal
***[[abdominal pain]]
***[[nausea]], [[vomiting]]
***[[diarrhea]]
***[[GI bleeding]]
***bowel [[ischemia]]
***[[pancreatitis]]
***[[hepatic]] necrosis
**CNS
***[[headache]]
***[[Dizziness]]
***[[Confusion]]
***[[Stroke]]
***[[Paraparesis]]
***[[Mononeuropathy]]
**Eye
***[[eye]] pain
*** transient loss of vision or [[amaurosis fugax]]
***[[blurry vision]]
**lung
***[[alveolar bleeding]]
**Muscle
***[[myositis]]
***[[Rhabdomyolysis]]
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
 


[[Category:Cardiology]]
[[Category:Cardiology]]
Line 10: Line 63:
[[Category:Vascular surgery]]
[[Category:Vascular surgery]]
[[Category:Disease]]
[[Category:Disease]]
 
[[Category:need English review]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 23:47, 14 February 2021

Cholesterol emboli syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cholesterol emboli syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholesterol emboli syndrome history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholesterol emboli syndrome history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholesterol emboli syndrome history and symptoms

CDC on Cholesterol emboli syndrome history and symptoms

Cholesterol emboli syndrome history and symptoms in the news

Blogs on Cholesterol emboli syndrome history and symptoms

Directions to Hospitals Treating Cholesterol emboli syndrome

Risk calculators and risk factors for Cholesterol emboli syndrome history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]

Overview

Clinical presentation is variable and depends on the organ involved by cholesterol crystals. Due to cholesterol embolization, many organs such as skin, kidneys, heart, gastrointestinal tract, nervous system, eyes, and skeletal muscles can be involved.

History

Symptoms

References

  1. 1.0 1.1 1.2 Ozkok, Abdullah (2019). "

    Cholesterol-embolization syndrome: current perspectives

    ". Vascular Health and Risk Management. Volume 15: 209–220. doi:10.2147/VHRM.S175150. ISSN 1178-2048.
  2. Falanga, Vincent (1986). "The Cutaneous Manifestations of Cholesterol Crystal Embolization". Archives of Dermatology. 122 (10): 1194. doi:10.1001/archderm.1986.01660220112024. ISSN 0003-987X.
  3. Quinones, Adriana; Saric, Muhamed (2013). "The Cholesterol Emboli Syndrome in Atherosclerosis". Current Atherosclerosis Reports. 15 (4). doi:10.1007/s11883-013-0315-y. ISSN 1523-3804.
  4. Saric, Muhamed; Kronzon, Itzhak (2011). "Cholesterol embolization syndrome". Current Opinion in Cardiology. 26 (6): 472–479. doi:10.1097/HCO.0b013e32834b7fdd. ISSN 0268-4705.

Template:WikiDoc Sources